Data integrity is key to the success of any cell therapy program. CDMOs can implement robust data management systems for ...

Adoptive therapies based on CAR/TCR T cells—that is, T cells with an engineered chimeric antigen receptor (CAR) or a T-cell receptor (TCR)—have shown promise for a range of cancers, offering hope to ...

SAN DIEGO—Cytiva has launched its Sefia next-generation manufacturing platform, with the goal of helping drug developers and larger healthcare providers accelerate their production of chimeric antigen ...

A little over a year after winning manufacturing certification for its cell therapy factory-in-a-box, South San Francisco’s Cellares has passed another major production milestone. Cellares’ automated ...

Whether for drug screening or toxicity testing, stem cell-based 3D tissue models are key to biomedical research. However, ...

When most people think of cancer care, they rarely associate it with what goes on behind the scenes to create life-saving treatments. For starters, developing cell and gene therapies is pricey, and ...

No country has affected global solar panel supply chains more than the United States. Since the boom of solar in the early ...

Cellares has joined forces with the Stanford Center for Definitive and Curative Medicine (CDCM) and Stanford Innovative ...

Half cell solar panels, which divide conventional full-sized cells into two electrically independent halves, have moved from a niche engineering concept to an industry standard in less than a decade.

Few robotics technologies have been actually deployed in high-mix manufacturing. Let's explore the reasons behind this slow ...